Cartalax 20mg

Cartalax – 20 mg

---

Overview:

Cartalax is a peptide bioregulator developed to support the health and regeneration of cartilage tissue and connective structures within the musculoskeletal system. It works by regulating gene expression and protein synthesis in chondrocytes (cartilage cells), enhancing their regenerative capacity. Cartalax is part of the Khavinson peptide family, specifically targeting joint, tendon, and cartilage repair. It is highly beneficial in joint degeneration, arthritis, sports injuries, and post-surgical recovery.

---

Brief History:

Created by Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology, Cartalax was designed to help regenerate and maintain cartilage tissue function. Used for decades in clinical settings throughout Europe and Russia, it has demonstrated effectiveness in restoring joint mobility, reducing inflammation, and preventing degenerative changes in cartilage associated with aging and overuse.

---

Therapeutic Uses:

1. Joint Repair and Cartilage Regeneration:
   • Purpose: Promotes repair of cartilage and connective tissues.
   • Benefits: Enhances joint mobility and reduces stiffness.
   • Dosage Example: 15–20 units SC injection 3x weekly for 4–6 weeks.
2. Arthritis and Degenerative Joint Disease:
   • Purpose: Reduces inflammation and slows progression of joint degradation.
   • Benefits: Eases pain and improves long-term joint function.
   • Dosage Example: 20 units SC 3x weekly for 8 weeks.
3. Post-Surgical and Injury Recovery:
   • Purpose: Accelerates tissue regeneration following joint or ligament surgery.
   • Benefits: Reduces recovery time and enhances tissue strength.
   • Dosage Example: 15 units SC 3x per week for 6–8 weeks.
4. Athletic and Physical Performance Support:
   • Purpose: Maintains cartilage resilience and reduces training-related wear.
   • Benefits: Supports recovery, endurance, and musculoskeletal balance.
   • Dosage Example: 10–15 units SC 2x per week during athletic cycles.
5. Anti-Aging and Preventive Joint Health:
   • Purpose: Prevents cartilage thinning and age-related joint deterioration.
   • Benefits: Maintains flexibility and long-term joint function.
   • Dosage Example: 10–15 units SC weekly in longevity programs.

---

Dosage and Administration:

• Reconstitution:
  • Reconstitute Cartalax 20 mg with 2 mL bacteriostatic water.
  • Final concentration: 10 mg/mL, with 1 unit = 100 mcg on a 1 mL (100-unit) insulin syringe.
• Typical Dose Range:
  • 10–20 units SC per injection depending on condition severity.

---

Method of Administration:

• Subcutaneous (Sub-Q) Injection: Main route for systemic regenerative and anti-inflammatory effects.
• Intramuscular (IM) Injection: Optional for deeper musculoskeletal penetration in chronic or severe cases.

---

Duration of Use:

• Initial Phase: 4–8 weeks, 2–3x weekly at 15–20 units.
• Maintenance Phase: 10 units SC weekly for continued cartilage protection.
• Longevity Phase: Repeat 2–3 treatment cycles per year for sustained joint integrity.

---

General Considerations:

• Synergy: Works effectively with Pinealon for neural-musculoskeletal coordination and Livagen for detox support in chronic inflammation cases. It may also be paired with Epithalon for long-term regenerative benefits.
• Side Effects: Minimal; occasional mild redness or tenderness at the injection site.
• Monitoring: Evaluate joint mobility, pain scores, and inflammation markers during therapy.

---

Conclusion:

Cartalax (20 mg) is a cartilage-targeting bioregulator designed to enhance tissue regeneration, reduce inflammation, and support joint longevity. It is highly effective for arthritis, injury recovery, and preventative aging protocols within musculoskeletal health management.

---

Category: Bioregulator / Cytomodulator Peptide